Allara, the women’s health company founded and led by Rachel Blank, has secured $30 million in new funding to expand its use of artificial intelligence, strengthen partnerships and support research.
Announced on 13 October 2026, the investment brings the company’s total funding to $75 million. Existing backers including Index Ventures and GV increased their commitments, alongside new investors Camino Partners, Foreground Capital and Family Fund.
Connecting women with integrated care
Allara combines clinicians and registered dietitians on a virtual platform addressing hormonal, metabolic and reproductive health. The company says it has served more than 120,000 women.
“We built Allara to treat women’s health as connected, because hormones, metabolism and life stage don’t work in isolation,” Blank said.
Bringing AI into the patient journey
The funding will support AI tools for intake, scheduling and ongoing treatment management. Allara says these tools are intended to give clinicians more time for patients, with healthcare providers remaining responsible for care decisions.
Expanding access and research
The company also plans to broaden healthcare partnerships and use patient insights to advance research into conditions including endometriosis and thyroid disorders.
